Sulfacetamide Sodium
Product Description
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Specifications
CLEARSYNTH LABS LIMITED
-
Country/Region:India
-
On CPHI since:2015
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
More Products from CLEARSYNTH LABS LIMITED (99)
-
Product Rac-Hydroxy Ezetimibe D4
Labeled Ezetimibe, intended for use as an internal standard for the quantification of Ezetimibe by GC- or LC-mass spectrometry. -
Product Racecadotril
Antidiarrheal; enkephalinase inhibitor, reducing the amount of water and electrolytes into the intestine. -
Product Selenous acid
It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION. -
Product 4-Hydroxy Atorvastatin D5 Disodium Salt
A labeled metabolite of Atorvastatin,;Labeled Atorvastatin, intended for use as an internal standard for the quantification of Atorvastatin by GC- or LC-mass spectrometry. -
Product Clomiphene Citrate D5
Labelled Clomiphene. Synthetic estrogen agonist-antagonist. Gonad-stimulating principle.;Labeled Clomiphene, intended for use as an internal standard for the quantification of Clomiphene by GC- or LC-mass spectrometry. -
Product Domperidone EP Impurity A
Intermediate and metabolite of the gastrokinetic and antinauseant drug Domperidone. -
Product Tamoxifen
Tamoxifen is a selective estrogen response modifier (SERM), protein kinase C inhibitor and anti-angiogenetic factor. Tamoxifen is a prodrug that is metabolized to active metabolites 4-hydroxytamoxifen (4-OHT) and endoxifen by cytochrome P450 isoforms CYP2D6 and CYP3A4. In breast cancer, the gene repressor ... -
Product 2,2-Dipyridylamine
A metal-complexing agent; an effective iron chelating agent to help protect against UVB radiation. An impurity of Chlorpheniramine Maleate . ;Impurity in commercial preparations of Chlorpheniramine. -
Product Nitrosamine and Drug Impurities | Testing and Analytical Services
Clearsynth is a globally trusted partner for reference standards and research chemicals. We offer over 3,000 nitrosamine impurities, 5,000+ stable isotopes, and 10,000+ drug impurities, encompassing a vast portfolio of more than 325,000 products serving various industries, including pharmaceuticals, clinic... -
Product Reference Standards and NMR Solvents
Clearsynth is Globally "Trusted" Partner for Reference Standards and Research Chemicals. An extensive range of 325,000+ products serves various industries such as pharma, clinical research, testing laboratories, etc. We specialize in Innovative Organic Chemistry and synthesis of Unique Complex Molecules... -
Product Deuterated Products
Specialised in Deuterium Chemistry, Clearsynth Manufactures Deuterated Reagents, Deuterated Intermediates and Deuterated APIs (such as Deutetrabenazine, Deuruxolitinib, Deutivacaftor, Deucravacitinib, Donafenib)
Production capacity from mg to tons scale.
Our key reagents are Benzene D... -
Product Pharmaceutical Secondary Standards
ClearSure by Clearsynth are Pharmaceutical Secondary Standards with extensive documentation traceable to Primary Reference Standards available in various pack size ranging from mg to g at affordable prices.
Caffeine , Metformin hydrochloride , Paracetamol (Acetaminophen), Ibuprofen , Omepraz...
CLEARSYNTH LABS LIMITED resources (1)
-
Video Clearsynth Intro Video
Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.











.png)